Obesity

Showing NaN - NaN of 96

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Obesity Trial in United States (pramlintide acetate)

Completed
  • Obesity
  • pramlintide acetate
  • Chula Vista, California
  • +20 more
Apr 9, 2015

Obesity Trial in Puerto Rico, United States (exenatide, )

Completed
  • Obesity
  • Peoria, Arizona
  • +15 more
Mar 19, 2015

Obesity, Overweight Trial in United States (AC2307, )

Completed
  • Obesity
  • Overweight
  • Birmingham, Alabama
  • +17 more
Jan 16, 2015

Obesity, Overweight, Diabetes, Type 2 Trial in United States (Naltrexone SR 32 mg/bupropion SR 360 mg/ day, Placebo, Ancillary

Completed
  • Obesity
  • +2 more
  • Naltrexone SR 32 mg/bupropion SR 360 mg/ day
  • +2 more
  • Fairhope, Alabama
  • +52 more
Nov 18, 2014

Obesity, Overweight Trial in United States (Naltrexone SR 16 mg/Bupropion SR 360 mg /day, Naltrexone SR 32 mg/Bupropion SR 360

Completed
  • Obesity
  • Overweight
  • Naltrexone SR 16 mg/Bupropion SR 360 mg /day
  • +3 more
  • Birmingham, Alabama
  • +33 more
Nov 18, 2014

Obesity, Overweight Trial in Baton Rouge, Durham, Goteborg (Orlistat, Placebo)

Completed
  • Obesity
  • Overweight
  • Baton Rouge, Louisiana
  • +2 more
Feb 28, 2013

Cardiovascular Diseases, Heart Diseases, Obesity Trial in Baton Rouge, Boston (Four Diets Differing in Macronutrient

Completed
  • Cardiovascular Diseases
  • +2 more
  • Four Diets Differing in Macronutrient Composition
  • Diets Low in Saturated Fat
  • Baton Rouge, Louisiana
  • +1 more
Jan 29, 2013

Obesity Trial in United States (Zonisamide SR / bupropion SR , Zonisamide SR / bupropion SR 360 mg/day, Zonisamide SR 120

Completed
  • Obesity
  • Zonisamide SR placebo/ bupropion SR placebo
  • +5 more
  • Fairhope, Alabama
  • +19 more
Nov 27, 2012

Obesity Trial in Worldwide (Placebo, CP-945,598, CP-945,598 Treatment B)

Terminated
  • Obesity
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +90 more
Nov 5, 2012

Obesity Trial in Canada, United States (CP-945,598 Treatment A, CP-945,598 Treatment B, Placebo)

Terminated
  • Obesity
  • CP-945,598 Treatment A
  • +2 more
  • Fairhope, Alabama
  • +81 more
Nov 5, 2012

Look At The Effect Of Two Investigational Drugs On Body Fat And

Completed
  • Hypercholesterolemia
  • +2 more
  • Baton Rouge, Louisiana
    GSK Investigational Site
Mar 15, 2012

Obesity Trial in United States (LY377604, Sibutramine, Metoprolol)

Terminated
  • Obesity
  • Mesa, Arizona
  • +20 more
Jun 2, 2011

Obesity Trial in United States (BMS-646256, Placebo)

Terminated
  • Obesity
  • Los Angeles, California
  • +9 more
Sep 15, 2010

Obesity, Menopause Trial in Baton Rouge (Individualized dietary-control and exercise program, Weight-management and smoking

Completed
  • Obesity
  • Menopause
  • Individualized dietary-control and exercise program
  • +2 more
  • Baton Rouge, Louisiana
    LSU Pennington Biomedical Research Center
Dec 9, 2009

Obesity Trial in United States (CP-945,598, sibutramine)

Completed
  • Obesity
  • Clearwater, Florida
  • +14 more
Aug 11, 2009

Obesity, Weight Loss Trial in Canada, United States (Rimonabant (SR141716))

Completed
  • Obesity
  • Weight Loss
  • Rimonabant (SR141716)
  • Birmingham, Alabama
  • +50 more
Apr 17, 2009

Obesity Trial in United States (Nasal Placebo, Placebo Capsule, PYY3-36)

Completed
  • Obesity
  • Nasal Placebo
  • +3 more
  • Peoria, Arizona
  • +28 more
Sep 12, 2008

Obesity Trial in United States (naltrexone and bupropion SR)

Completed
  • Obesity
  • naltrexone and bupropion SR
  • San Diego, California
  • +6 more
Apr 18, 2008

Obesity Trial in United States (Zonisamide CR and Bupropion SR, Placebo)

Completed
  • Obesity
  • Zonisamide CR and Bupropion SR
  • Placebo
  • Fairhope, Alabama
  • +14 more
Apr 18, 2008

Obesity Trial in Baton Rouge, Salt Lake City, Basel (oleoyl-estrone (MP 101))

Unknown status
  • Obesity
  • oleoyl-estrone (MP 101)
  • Baton Rouge, Louisiana
  • +2 more
Mar 16, 2007